抗体
试剂盒
多肽
探针
蛋白
组织芯片
产品中心
Product Center
Research Grade Dalotuzumab
All
TD-HY353016_1.jpg
TD-HY353016_2.jpg
- Catalog： TD-HY353016
- Clonality： mAb
- Application： Research Grade Biosimilar
- Synonyms： MK-0646,CAS:1005389-60-5
-
规格：
1mg
-
价格：
¥询价
定制服务咨询
Research Grade Dalotuzumab
| Catalog No. | TD-HY353016 |
|---|---|
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Host species | Humanized |
| Isotype | IgG1-kappa |
| Expression system | Mammalian Cells |
| Clonality | Monoclonal |
| Target | CD221, Insulin-like growth factor 1 receptor, IGF1R, Insulin-like growth factor I receptor, IGF-I receptor |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G, purified from cell culture supernatant. |
| Accession | P08069 |
| Form | Liquid |
| Storage buffer | 0.01M PBS,pH7.4. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. |
| Alternate Names | MK-0646,CAS:1005389-60-5 |
| Background | Dalotuzumab (MK-0646) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation. Dalotuzumab also induces apoptosis and cycle arrest. Dalotuzumab in combination with other anticancer agents such as statins can enhance the antitumor activity of Dalotuzumab in vitro and in vivo. |
| Note | For research use only. Not for use in clinical or therapeutic applications. |
|
|
Detects Human CD221/IGF1R in indirect ELISAs. |
|
|
SDS-PAGE for Research Grade Dalotuzumab. |